Physician profile
Julia Ansari
NPI 1780846881
$24,308.71
in general payments reported to CMS, 2019-2025
37 companies · $1,895 in 2025
The $1,895 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $603 · 2021: $966 · 2022: $1,229 · 2023: $6,610 · 2024: $2,484 · 2025: $1,895.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,949 · Food and Beverage: $5,040.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,949.05 |
| Food and Beverage | $5,040.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $10,673.37 | 2019-2025 | Watchman Flx, Watchman Access System, General - Ep |
| Medtronic, INC. | $4,917.73 | 2021-2025 | Corevalve Evolut R, Advisa Dr Mri Surescan, Azure Xt Dr Mri Surescan |
| Abbott Laboratories | $1,871.04 | 2020-2025 | Amplatzer, Cardiomems, Jot Dx |
| Abiomed | $1,760.15 | 2019-2025 | Impella |
| Penumbra, INC. | $861.43 | 2023 | Indigo System |
| Biosense Webster, INC. | $748.83 | 2023-2025 | Carto 3, Nuvision Ice Catheter, Octaray Mapping Catheter |
| Inari Medical, INC. | $527.05 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $373.93 | 2021-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $274.87 | 2020-2024 | Lifevest |
| Novartis Pharmaceuticals Corporation | $261.69 | 2022-2025 | |
| Medtronic Vascular, INC. | $251.74 | 2019-2020 | |
| Pfizer INC. | $226.58 | 2020-2024 | |
| Edwards Lifesciences Corporation | $216.35 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $206.87 | 2021-2023 | Xarelto |
| Recor Medical INC | $189.75 | 2024 | Paradise Renal Denervation System |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Ansari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.